Stay updated with breaking news from Amarin Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amarin Co. plc (NASDAQ:AMRN – Get Rating) has earned an average rating of “Hold” from the four analysts that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating on the company. The average […]
Amarin Co. plc (NASDAQ:AMRN – Get Rating) has received a consensus recommendation of “Hold” from the four brokerages that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month […]
Amarin Co. plc (NASDAQ:AMRN – Get Rating) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 23,860,000 shares, a growth of 7.4% from the March 31st total of 22,220,000 shares. Based on an average trading volume of 4,060,000 shares, the days-to-cover ratio is […]
Amarin Co. plc (NASDAQ:AMRN – Get Rating)’s stock price was up 7% during mid-day trading on Friday . The stock traded as high as $1.36 and last traded at $1.36. Approximately 837,467 shares changed hands during mid-day trading, a decline of 79% from the average daily volume of 4,077,538 shares. The stock had previously closed […]
Amarin Co. plc (NASDAQ:AMRN – Get Rating) – Stock analysts at Jefferies Financial Group issued their Q1 2023 earnings per share (EPS) estimates for shares of Amarin in a research report issued on Sunday, April 16th. Jefferies Financial Group analyst M. Yee expects that the biopharmaceutical company will earn ($0.02) per share for the quarter. […]